Benjamin Edwards Inc’s Jazz Pharmaceuticals JAZZ Stock Holding History

Benjamin Edwards Inc’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$255K	Buy	+1,102	New	+$272K	﹤0.01%	1321

Other funds holding JAZZ

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $54.1B AUM 39.29% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return

Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return

Benjamin Edwards Inc's JAZZ Position: Q3 2026 in Review

Benjamin Edwards Inc opened a new position in Jazz Pharmaceuticals (JAZZ) in Q3 2026: 1,102 shares worth $255K. The stake represents ﹤0.01% of the portfolio and ranks #1321 among its holdings.

474 funds tracked by Wall St. Rank hold JAZZ as of Q3 2026.

Benjamin Edwards Inc held 1,102 shares of Jazz Pharmaceuticals worth $255K as of Q3 2026.
Jazz Pharmaceuticals was a new Benjamin Edwards Inc position in Q3 2026.
Jazz Pharmaceuticals made up ﹤0.01% of Benjamin Edwards Inc's portfolio in Q3 2026, its #1321 holding.
474 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2026.

Based on Benjamin Edwards Inc's 13F filing for Q3 2026, filed 12 Nov 2026.